Skip to content

Kefir review finds lower glucose, with other outcomes uncertain

Pooled intervention studies reported lower fasting glucose and an insulin-resistance measure, without statistically significant changes in body measurements, blood lipids or inflammation.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The pooled results suggest that kefir consumption may lower fasting blood glucose and HOMA-IR, an insulin-resistance measure. The analysis did not detect statistically significant effects on body measurements, blood lipids or inflammatory markers. These selective findings do not establish a broad metabolic benefit or show that clinical health outcomes improved.

Keep in mind

The abstract omits participant health profiles, intervention durations, control conditions and confidence intervals for the glucose results, making their precision and practical importance difficult to judge.

THE NUMBERS, WITH CONTEXT

What researchers found

Mean difference -8.46 mg/dL; p = 0.006

Fasting blood glucose

Kefir versus study control groups; treatment timeframe: Not reported in the abstract.

Nutr Metab Cardiovasc Dis, 2026 · Original source ↓

Different outcomes, different results

Researchers combined intervention studies and examined several distinct outcomes. A reduction in a glucose marker does not establish changes in body size, cholesterol or inflammation; those outcomes were assessed separately.

Dose details remain unavailable

The authors explored results by kefir dosage, but the abstract provides no dose-specific estimates. It therefore cannot identify an effective dose, show dose superiority or support a particular consumption schedule.

CHECK THE ORIGINAL

The original publication

Effect of different kefir dosages on inflammation status, metabolic profile, and anthropometric measurements in adults: A systematic review and meta-analysis.

Hamsho M, Hawari R, Yeşil Z et al.
Nutr Metab Cardiovasc Dis · 2026

PubMed ID
41076330
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.